NantHealth, Inc. (NHIQ)
USD 0.25
(12399.98%)
USD 0.25
(12399.98%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -32.26 Million | -27.68 Million | -16.85 Million | -8.76 Million | -29.63 Million | -81.14 Million |
| Net Income | -67.77 Million | -58.54 Million | -56.44 Million | -62.76 Million | -192.15 Million | -175.21 Million |
| Depreciation & Amortization | 15.99 Million | 15.72 Million | 16.77 Million | 22.36 Million | 22.35 Million | 28.05 Million |
| Deferred income taxes | -632 Thousand | -78 Thousand | -23 Thousand | -560 Thousand | -3.76 Million | 5.05 Million |
| Stock-based compensation | 4.66 Million | 3.88 Million | 2.64 Million | 2.78 Million | 5.65 Million | 4.51 Million |
| Change in working capital | 12.17 Million | 7.51 Million | 2.19 Million | 5.86 Million | 5.93 Million | -8.6 Million |
| Other non-cash items | 3.31 Million | 3.8 Million | 18 Million | 23.54 Million | 132.34 Million | 65.04 Million |
| Investing Cash Flow | -6.47 Million | -5.63 Million | 35.25 Million | -4.29 Million | -10.47 Million | -12.27 Million |
| Investments in PPE | -6.47 Million | -5.08 Million | -5.67 Million | -4.59 Million | -10.54 Million | -13.63 Million |
| Acquisitions | - | -556 Thousand | 40.92 Million | 300 Thousand | 68 Thousand | 1.72 Million |
| Investment purchases | - | - | - | - | - | -360 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -556 Thousand | 46.4 Million | 300 Thousand | - | 1.36 Million |
| Financing Cash Flow | 10.8 Million | 40.57 Million | -555 Thousand | -32 Thousand | -2.15 Million | -5.33 Million |
| Debt repayment | -1.88 Million | -98.81 Million | -1.84 Million | -1.4 Million | -93 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -739 Thousand | -270 Thousand | -2.06 Million | -5.33 Million |
| Common Stock Issuance | 24 Thousand | 291 Thousand | 171 Thousand | - | - | - |
| Other Financing Activities | 12.65 Million | 139.09 Million | 1.11 Million | 1.37 Million | -2.06 Million | -5.33 Million |
| Accounts receivables | -204 Thousand | -2.66 Million | 4.78 Million | 3.31 Million | 406 Thousand | 4000.00 |
| Accounts payables | 7.21 Million | -1.91 Million | 1.43 Million | 1.36 Million | -1.66 Million | -1.85 Million |
| Inventory | 6.2 Million | 9.62 Million | -18 Thousand | -302 Thousand | 343 Thousand | 196 Thousand |
| Other working capital | -1.03 Million | 2.46 Million | -4 Million | 1.48 Million | 6.85 Million | -6.95 Million |
| Cash at beginning of period | 31.4 Million | 24.16 Million | 6.37 Million | 19.44 Million | 62.01 Million | 160.35 Million |
| Cash at end of period | 3.55 Million | 31.4 Million | 24.16 Million | 6.37 Million | 19.44 Million | 61.66 Million |
| Capital Expenditure | -6.47 Million | -5.08 Million | -5.67 Million | -4.59 Million | -10.54 Million | -13.63 Million |
| Effect of forex changes on cash | 91 Thousand | -11 Thousand | -62 Thousand | 25 Thousand | -300 Thousand | 65 Thousand |
| Net cash flow / Change in cash | -27.84 Million | 7.24 Million | 17.78 Million | -13.06 Million | -42.56 Million | -98.69 Million |
| Free Cash Flow | -38.73 Million | -32.77 Million | -22.52 Million | -13.35 Million | -40.17 Million | -94.78 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.98 Million | -17.48 Million | -12.24 Million | -67.77 Million | -25.66 Million | -13.65 Million |
| Depreciation & Amortization | 3.82 Million | 2.99 Million | 2.94 Million | 15.99 Million | 4.08 Million | 4.01 Million |
| Deferred income taxes | 4000.00 | 9000.00 | 25 Thousand | -632 Thousand | -350 Thousand | -68 Thousand |
| Stock-based compensation | 670 Thousand | 764 Thousand | 876 Thousand | 4.66 Million | 1.12 Million | 889 Thousand |
| Change in working capital | -2.41 Million | 2.97 Million | 5.52 Million | 12.17 Million | 4.63 Million | 7.41 Million |
| Other non-cash items | 5.25 Million | 4.37 Million | -3.7 Million | 3.31 Million | 9.12 Million | -3.61 Million |
| Investing Cash Flow | 11 Thousand | -810 Thousand | -1.26 Million | -6.47 Million | -2.31 Million | -1.29 Million |
| Investments in PPE | 11 Thousand | -810 Thousand | -1.26 Million | -6.47 Million | -2.31 Million | -1.29 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 7.5 Million | -425 Thousand | 20.6 Million | 10.8 Million | 10.44 Million | 1.11 Million |
| Debt repayment | - | -425 Thousand | -560 Thousand | -1.88 Million | -553 Thousand | -545 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.5 Million | - | - | 24 Thousand | - | - |
| Other Financing Activities | 7.5 Million | -425 Thousand | 21.16 Million | 12.65 Million | 11 Million | 1.65 Million |
| Accounts receivables | 955 Thousand | 1.13 Million | -793 Thousand | -204 Thousand | -684 Thousand | -261 Thousand |
| Accounts payables | 469 Thousand | -3.56 Million | -648 Thousand | 7.21 Million | 4.18 Million | 1.38 Million |
| Inventory | -4.9 Million | 6.42 Million | 6.73 Million | 6.2 Million | 1.57 Million | 6.32 Million |
| Other working capital | 1.06 Million | -1.03 Million | 235 Thousand | -1.03 Million | -440 Thousand | -37 Thousand |
| Cash at beginning of period | 7.97 Million | 15.94 Million | 3.55 Million | 31.4 Million | 2.43 Million | 7.51 Million |
| Cash at end of period | 7.67 Million | 7.97 Million | 15.94 Million | 3.55 Million | 3.55 Million | 2.43 Million |
| Capital Expenditure | 11 Thousand | -810 Thousand | -1.26 Million | -6.47 Million | -2.31 Million | -1.29 Million |
| Effect of forex changes on cash | -155 Thousand | -372 Thousand | -376 Thousand | 91 Thousand | 38 Thousand | 131 Thousand |
| Net cash flow / Change in cash | -298 Thousand | -7.97 Million | 12.39 Million | -27.84 Million | 1.12 Million | -5.07 Million |
| Free Cash Flow | -7.64 Million | -7.17 Million | -7.83 Million | -38.73 Million | -9.36 Million | -6.31 Million |
KTWIF
AJANTPHARM
7472
1157
GMLA
8028